Boothbay Fund Management, LLC Blueprint Medicines Corp Transaction History
Boothbay Fund Management, LLC
- $3.6 Billion
- Q3 2024
A detailed history of Boothbay Fund Management, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 24,862 shares of BPMC stock, worth $2.53 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
24,862Holding current value
$2.53 Million% of portfolio
0.06%Shares
12 transactions
Others Institutions Holding BPMC
# of Institutions
362Shares Held
61.8MCall Options Held
2.24MPut Options Held
1.15M-
Vanguard Group Inc Valley Forge, PA6.77MShares$688 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$675 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$547 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$403 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$281 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.07B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...